Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of LN-145 (tumor infiltrating lymphocytes) with cyclophosphamide, fludarabine, and aldesleukin in patients with recurrent, metastatic, or persistent cervical cancer

    Not recruiting

    1 1 1
    France Germany Italy The Netherlands Spain
  • Study of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1
    Belgium France Germany Italy Poland Spain
  • Comparing Methotrexate and Tocilizumab for Treating Giant Cell Arteritis in Patients: A Study on Effectiveness and Safety

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France
  • Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety

    Not recruiting

    1 1
    Investigated drugs:
    Belgium Czechia Germany Hungary Italy Poland +4
  • Study Comparing Cisplatin and Radiotherapy with Durvalumab and Radiotherapy for Patients with Intermediate Risk HPV-Positive Oropharyngeal Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium Italy Spain
  • Study on the Long-Term Safety of Alpelisib for Patients with PIK3CA-Related Overgrowth Spectrum (PROS)

    Not recruiting

    1 1
    Investigated drugs:
    France Ireland Spain
  • Study on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus

    Not recruiting

    1 1 1
    Investigated drugs:
    Czechia France Italy Poland Spain
  • Study on Upadacitinib for Pain Management in Patients with Psoriatic Arthritis

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Germany
  • Study on Alpelisib with Fulvestrant or Letrozole for Patients with Advanced Breast Cancer and PIK3CA Mutation After Previous Treatments

    Not recruiting

    1 1 1
    Denmark Italy
  • Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

    Not recruiting

    1 1 1 1
    Austria Belgium Czechia Finland France Germany +7